Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,434 | -67,627 | -23,403 | -24,342 | 3,255 |
| Depreciation Amortization | 569 | 438 | 220 | 1,132 | 872 |
| Accounts payable and accrued liabilities | 38,127 | 35,168 | 538 | -2,919 | 41,671 |
| Other Working Capital | 41,153 | 41,100 | 6,622 | -1,827 | 37,845 |
| Other Operating Activity | -23,919 | -25,362 | 4,687 | -88,973 | -139,307 |
| Operating Cash Flow | $-22,504 | $-16,283 | $-11,336 | $-116,929 | $-55,664 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | N/A | N/A | -103 | -46 |
| Investing Cash Flow | $-80 | $N/A | $N/A | $-103 | $-46 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 90 | 90 | 90 | 124,470 | 123,552 |
| Financing Cash Flow | $90 | $90 | $90 | $124,470 | $123,552 |
| Beginning Cash Position | 128,574 | 128,574 | 128,574 | 121,136 | 121,136 |
| End Cash Position | 106,080 | 112,381 | 117,328 | 128,574 | 188,978 |
| Net Cash Flow | $-22,494 | $-16,193 | $-11,246 | $7,438 | $67,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,504 | -16,283 | -11,336 | -116,929 | -55,664 |
| Capital Expenditure | -80 | N/A | N/A | -103 | -46 |
| Free Cash Flow | -22,584 | -16,283 | -11,336 | -117,032 | -55,710 |